Cargando…
Procollagen-lysine, 2-oxoglutarate 5-dioxygenases 1, 2, and 3 are potential prognostic indicators in patients with clear cell renal cell carcinoma
Intratumoral fibrosis is a frequent histologic finding in highly vascularized clear cell renal cell carcinoma (ccRCC). Here, we investigated the expression of a family of collagen-modifying enzymes, procollagen-lysine, 2-oxoglutarate 5-dioxygenases 1, 2, and 3 (PLOD1/2/3), in ccRCC tissues and asses...
Autores principales: | Xu, Wen-Hao, Xu, Yue, Wang, Jun, Tian, Xi, Wu, Junlong, Wan, Fang-Ning, Wang, Hong-Kai, Qu, Yuan-Yuan, Zhang, Hai-Liang, Ye, Ding-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738415/ https://www.ncbi.nlm.nih.gov/pubmed/31446433 http://dx.doi.org/10.18632/aging.102206 |
Ejemplares similares
-
Procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 promotes hypoxia-induced glioma migration and invasion
por: Xu, Yangyang, et al.
Publicado: (2017) -
Correction: Procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 promotes hypoxia-induced glioma migration and invasion
por: Xu, Yangyang, et al.
Publicado: (2021) -
Exome sequencing identifies procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 mutations in primary congenital and juvenile glaucoma
por: Gupta, Viney, et al.
Publicado: (2021) -
A Human Pan-Cancer System Analysis of Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase 3 (PLOD3)
por: Gong, Siming, et al.
Publicado: (2021) -
Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase Family: Novel Prognostic Biomarkers and Tumor Microenvironment Regulators for Lower-Grade Glioma
por: Gong, Siming, et al.
Publicado: (2022)